ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was…
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical…
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics…
Discover a neuroscience-based path to better mental health and executive well-being with Grey Matters International. Their personalized retreats combine brain…
Memphis, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- The Methodist Healthcare Foundation will welcome Academy Award-winning actress and breast cancer…
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has…
Mothers channel loss into a $1.5 million commitment to fund childhood cancer research.HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Five…
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Memory lapses, poor concentration, and mental fatigue are no longer just signs…
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory…
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025 (Pursuant to Article L.233-8 II of the…